Today Krieen launches Katalog Health, a new venture that turns static pharma product PDFs into visual, searchable and easy-to-update interactive portfolios.
Pharma B2B SaaS
The first software that creates interactive B2B product lists. A platform built for more effective business development.
In B2B pharma, years go into building a strong portfolio. Yet when it is time to present that work to potential partners, the product list is often reduced to a static PDF: dense, difficult to search and outdated as soon as the portfolio changes.
We think product lists deserve better. Today, krieen is launching katalog.health, a new venture built to turn B2B pharma portfolios into interactive product lists.
With Katalog Health, business-development teams can make products easier to discover, give every asset the context it deserves and update information in seconds. The result is a clearer, more useful experience for both the team managing the portfolio and the partners exploring it.
The first Katalog experiences are designed for B2B out-licensing, where a strong first impression and fast access to the right information can open better conversations. Visual presentation, structured search and simple updates come together in one tool built around the way pharma teams actually work.
Co-Founders Alex Krieger Ollé and Marc Krieger Ollé will be at CPHI Milan next week, meeting companies who want to rethink how they present their portfolios.
If you work in B2B out-licensing, get in touch and we will show you what your product list could look like in Katalog. See you in Milan.
Before Katalog, presenting our full portfolio meant sending over a PDF and just hoping the right products got noticed. Now we can walk a partner through the products that actually matter to them. It has changed how we come across in those first meetings.
Katalog puts all our product information in one place, so the whole team works from a single source of truth. If a customer asks for a marketing authorization approval date, we don't have to check with RA anymore. We already have the answer.
